Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.01
COO's Cash to Debt is ranked lower than
98% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.56 vs. COO: 0.01 )
Ranked among companies with meaningful Cash to Debt only.
COO' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.06 Max: 1.92
Current: 0.01
0
1.92
Equity to Asset 0.60
COO's Equity to Asset is ranked lower than
54% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. COO: 0.60 )
Ranked among companies with meaningful Equity to Asset only.
COO' s Equity to Asset Range Over the Past 10 Years
Min: 0.15  Med: 0.60 Max: 0.77
Current: 0.6
0.15
0.77
Interest Coverage 13.07
COO's Interest Coverage is ranked lower than
66% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.90 vs. COO: 13.07 )
Ranked among companies with meaningful Interest Coverage only.
COO' s Interest Coverage Range Over the Past 10 Years
Min: 1.07  Med: 9.13 Max: 38.48
Current: 13.07
1.07
38.48
F-Score: 3
Z-Score: 3.40
M-Score: -2.91
WACC vs ROIC
4.47%
5.72%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 13.17
COO's Operating margin (%) is ranked higher than
70% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.71 vs. COO: 13.17 )
Ranked among companies with meaningful Operating margin (%) only.
COO' s Operating margin (%) Range Over the Past 10 Years
Min: 4.82  Med: 15.13 Max: 19.61
Current: 13.17
4.82
19.61
Net-margin (%) 11.33
COO's Net-margin (%) is ranked higher than
75% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.63 vs. COO: 11.33 )
Ranked among companies with meaningful Net-margin (%) only.
COO' s Net-margin (%) Range Over the Past 10 Years
Min: -1.18  Med: 10.54 Max: 18.65
Current: 11.33
-1.18
18.65
ROE (%) 7.81
COO's ROE (%) is ranked higher than
57% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.28 vs. COO: 7.81 )
Ranked among companies with meaningful ROE (%) only.
COO' s ROE (%) Range Over the Past 10 Years
Min: -0.79  Med: 7.40 Max: 12.88
Current: 7.81
-0.79
12.88
ROA (%) 4.61
COO's ROA (%) is ranked higher than
63% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. COO: 4.61 )
Ranked among companies with meaningful ROA (%) only.
COO' s ROA (%) Range Over the Past 10 Years
Min: -0.45  Med: 4.50 Max: 9.74
Current: 4.61
-0.45
9.74
ROC (Joel Greenblatt) (%) 16.29
COO's ROC (Joel Greenblatt) (%) is ranked higher than
61% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.36 vs. COO: 16.29 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
COO' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 5.39  Med: 17.35 Max: 29.5
Current: 16.29
5.39
29.5
Revenue Growth (3Y)(%) 7.50
COO's Revenue Growth (3Y)(%) is ranked higher than
65% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. COO: 7.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
COO' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 5.4  Med: 13.40 Max: 27.8
Current: 7.5
5.4
27.8
EBITDA Growth (3Y)(%) 2.10
COO's EBITDA Growth (3Y)(%) is ranked lower than
57% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.60 vs. COO: 2.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
COO' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -8.6  Med: 16.00 Max: 62.2
Current: 2.1
-8.6
62.2
EPS Growth (3Y)(%) -6.40
COO's EPS Growth (3Y)(%) is ranked lower than
69% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.40 vs. COO: -6.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
COO' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -15.2  Med: 14.90 Max: 37.5
Current: -6.4
-15.2
37.5
» COO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

COO Guru Trades in Q1 2015

Ken Fisher 72,657 sh (+6.03%)
Steve Mandel Sold Out
Ron Baron 352,815 sh (-0.83%)
Mario Gabelli 28,500 sh (-17.39%)
Jim Simons 112,298 sh (-49.66%)
» More
Q2 2015

COO Guru Trades in Q2 2015

Andreas Halvorsen 273,563 sh (New)
Ken Fisher 78,332 sh (+7.81%)
Mario Gabelli 28,500 sh (unchged)
Ron Baron 344,233 sh (-2.43%)
Jim Simons 30,898 sh (-72.49%)
» More
Q3 2015

COO Guru Trades in Q3 2015

Pioneer Investments 27,668 sh (New)
Paul Tudor Jones 3,231 sh (New)
Ray Dalio 2,897 sh (New)
Jim Simons 114,004 sh (+268.97%)
Ken Fisher 92,583 sh (+18.19%)
Mario Gabelli 28,500 sh (unchged)
Andreas Halvorsen Sold Out
Ron Baron 334,134 sh (-2.93%)
» More
Q4 2015

COO Guru Trades in Q4 2015

Ken Fisher 93,854 sh (+1.37%)
Mario Gabelli 28,500 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with COO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on The Cooper Companies Inc

Baron Funds Comments on The Cooper Companies - Jan 26, 2016

Shares of The Cooper Companies, Inc. (NYSE:COO), a global contact lens manufacturer, fell after its earnings fell short of Wall Street expectations. Results were negatively impacted by missteps in integrating its recent acquisition of Sauflon Pharmaceuticals Ltd., a British contact lens company, as well as fallout from new competitive lenses. Management projected moderating market share gains and lowered the company’s targeted five-year growth rate. Although disappointed, we remain cautiously optimistic, given Cooper’s reduced valuation and our belief that its revised earnings targets are achievable. Furthermore, we believe that shifts in the contact lens market toward greater adoption of silicon hydrogel lenses and daily modalities will play to Cooper’s strengths.



From Baron Funds' Baron Asset Fund commentary for fourth quarter 2015.



Check out Ron Baron latest stock trades

Baron Funds Comments on The Cooper Companies - May 02, 2014

We established a position in The Cooper Companies, Inc. (NYSE:COO) during the quarter. Cooper's primary business is manufacturing contact lenses, and it also has a relatively small unit focused on women's health products. There are several characteristics of the contact lens market that we find attractive. There are just four global players that account for the large bulk of the industry's sales, barriers to entry are high, and pricing trends are stable. The industry has grown at a mid-single digit rate for the past several years, and we believe that several developments should cause this growth rate to accelerate going forward. These include the widespread adoption of Silicon Hydrogel lenses, which provide a more comfortable user experience; recent technological advances that have led to lenses that can address a wider variety of vision deficiencies; the increasing conversion of bi-weekly contact users to daily-use lenses (which results in higher revenues for the manufacturer); and, the ongoing growth of the middle classes in emerging markets, which allows new entrants into the contact market.



Cooper is the third largest lens manufacturer with approximately 20% market share. The company has grown its share in recent years by introducing technologically superior products, particularly in the fast- growing Silicon Hydrogel market segment. We believe that Cooper can continue to grow at an above-market rate by further penetrating the global market with its superior products and by converting existing users from bi- weekly to daily contacts. In addition, we believe that Cooper should be able to expand its operating margins at a faster rate than revenues, as its Silicon Hydrogel lenses carry meaningfully higher gross margins than its legacy products, and sales growth will allow the company to leverage its fixed overheard. We believe Cooper will be able to grow its earnings per share at a high-teens rate for the next several years.



From Baron Funds' first quarter 2014 letter to investors.



Check out Ron Baron latest stock trades

Top Ranked Articles about The Cooper Companies Inc

Baron Funds Comments on The Cooper Companies Guru stock highlight
Shares of The Cooper Companies, Inc. (NYSE:COO), a global contact lens manufacturer, fell after its earnings fell short of Wall Street expectations. Results were negatively impacted by missteps in integrating its recent acquisition of Sauflon Pharmaceuticals Ltd., a British contact lens company, as well as fallout from new competitive lenses. Management projected moderating market share gains and lowered the company’s targeted five-year growth rate. Although disappointed, we remain cautiously optimistic, given Cooper’s reduced valuation and our belief that its revised earnings targets are achievable. Furthermore, we believe that shifts in the contact lens market toward greater adoption of silicon hydrogel lenses and daily modalities will play to Cooper’s strengths. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 31.50
COO's P/E(ttm) is ranked lower than
60% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.47 vs. COO: 31.50 )
Ranked among companies with meaningful P/E(ttm) only.
COO' s P/E(ttm) Range Over the Past 10 Years
Min: 7.98  Med: 22.31 Max: 1011.75
Current: 31.5
7.98
1011.75
Forward P/E 13.95
COO's Forward P/E is ranked higher than
82% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.84 vs. COO: 13.95 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 31.50
COO's PE(NRI) is ranked lower than
55% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.63 vs. COO: 31.50 )
Ranked among companies with meaningful PE(NRI) only.
COO' s PE(NRI) Range Over the Past 10 Years
Min: 8.11  Med: 22.32 Max: 2023.5
Current: 31.5
8.11
2023.5
P/B 2.27
COO's P/B is ranked higher than
53% of the 255 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. COO: 2.27 )
Ranked among companies with meaningful P/B only.
COO' s P/B Range Over the Past 10 Years
Min: 0.37  Med: 1.81 Max: 3.62
Current: 2.27
0.37
3.62
P/S 3.46
COO's P/S is ranked lower than
75% of the 255 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.28 vs. COO: 3.46 )
Ranked among companies with meaningful P/S only.
COO' s P/S Range Over the Past 10 Years
Min: 0.51  Med: 2.84 Max: 5.22
Current: 3.46
0.51
5.22
PFCF 32.23
COO's PFCF is ranked lower than
61% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.35 vs. COO: 32.23 )
Ranked among companies with meaningful PFCF only.
COO' s PFCF Range Over the Past 10 Years
Min: 7.34  Med: 26.51 Max: 342.65
Current: 32.23
7.34
342.65
POCF 14.21
COO's POCF is ranked higher than
58% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.75 vs. COO: 14.21 )
Ranked among companies with meaningful POCF only.
COO' s POCF Range Over the Past 10 Years
Min: 5.51  Med: 14.43 Max: 21.95
Current: 14.21
5.51
21.95
EV-to-EBIT 32.33
COO's EV-to-EBIT is ranked lower than
72% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.06 vs. COO: 32.33 )
Ranked among companies with meaningful EV-to-EBIT only.
COO' s EV-to-EBIT Range Over the Past 10 Years
Min: 11.2  Med: 21.00 Max: 72.2
Current: 32.33
11.2
72.2
EV-to-EBITDA 17.99
COO's EV-to-EBITDA is ranked lower than
57% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.72 vs. COO: 17.99 )
Ranked among companies with meaningful EV-to-EBITDA only.
COO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.8  Med: 14.90 Max: 26.5
Current: 17.99
6.8
26.5
PEG 3.07
COO's PEG is ranked lower than
55% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.97 vs. COO: 3.07 )
Ranked among companies with meaningful PEG only.
COO' s PEG Range Over the Past 10 Years
Min: 0.79  Med: 1.81 Max: 22.31
Current: 3.07
0.79
22.31
Shiller P/E 38.95
COO's Shiller P/E is ranked lower than
60% of the 73 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 34.34 vs. COO: 38.95 )
Ranked among companies with meaningful Shiller P/E only.
COO' s Shiller P/E Range Over the Past 10 Years
Min: 7.16  Med: 32.79 Max: 59.69
Current: 38.95
7.16
59.69
Current Ratio 1.48
COO's Current Ratio is ranked lower than
76% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.65 vs. COO: 1.48 )
Ranked among companies with meaningful Current Ratio only.
COO' s Current Ratio Range Over the Past 10 Years
Min: 1.28  Med: 2.17 Max: 3.46
Current: 1.48
1.28
3.46
Quick Ratio 0.74
COO's Quick Ratio is ranked lower than
88% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.69 vs. COO: 0.74 )
Ranked among companies with meaningful Quick Ratio only.
COO' s Quick Ratio Range Over the Past 10 Years
Min: 0.74  Med: 1.21 Max: 2.95
Current: 0.74
0.74
2.95
Days Inventory 200.86
COO's Days Inventory is ranked lower than
73% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 131.52 vs. COO: 200.86 )
Ranked among companies with meaningful Days Inventory only.
COO' s Days Inventory Range Over the Past 10 Years
Min: 167.05  Med: 207.61 Max: 231.4
Current: 200.86
167.05
231.4
Days Sales Outstanding 57.46
COO's Days Sales Outstanding is ranked higher than
64% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 64.05 vs. COO: 57.46 )
Ranked among companies with meaningful Days Sales Outstanding only.
COO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.77  Med: 58.81 Max: 63.16
Current: 57.46
52.77
63.16
Days Payable 58.71
COO's Days Payable is ranked higher than
52% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 55.85 vs. COO: 58.71 )
Ranked among companies with meaningful Days Payable only.
COO' s Days Payable Range Over the Past 10 Years
Min: 27.82  Med: 55.91 Max: 72.43
Current: 58.71
27.82
72.43

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.05
COO's Dividend Yield is ranked lower than
100% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.43 vs. COO: 0.05 )
Ranked among companies with meaningful Dividend Yield only.
COO' s Dividend Yield Range Over the Past 10 Years
Min: 0.03  Med: 0.09 Max: 0.52
Current: 0.05
0.03
0.52
Dividend Payout 0.01
COO's Dividend Payout is ranked higher than
99% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.36 vs. COO: 0.01 )
Ranked among companies with meaningful Dividend Payout only.
COO' s Dividend Payout Range Over the Past 10 Years
Min: 0.01  Med: 0.03 Max: 0.04
Current: 0.01
0.01
0.04
Forward Dividend Yield 0.05
COO's Forward Dividend Yield is ranked lower than
100% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.43 vs. COO: 0.05 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.05
COO's Yield on cost (5-Year) is ranked lower than
98% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. COO: 0.05 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
COO' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.03  Med: 0.09 Max: 0.52
Current: 0.05
0.03
0.52

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 101.97
COO's Price/Tangible Book is ranked lower than
98% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.59 vs. COO: 101.97 )
Ranked among companies with meaningful Price/Tangible Book only.
COO' s Price/Tangible Book Range Over the Past 10 Years
Min: 4.48  Med: 7.65 Max: 180.09
Current: 101.97
4.48
180.09
Price/Projected FCF 1.26
COO's Price/Projected FCF is ranked higher than
72% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.83 vs. COO: 1.26 )
Ranked among companies with meaningful Price/Projected FCF only.
COO' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.55  Med: 1.65 Max: 4
Current: 1.26
0.55
4
Price/DCF (Earnings Based) 3.86
COO's Price/DCF (Earnings Based) is ranked lower than
88% of the 40 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.78 vs. COO: 3.86 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.20
COO's Price/Median PS Value is ranked higher than
62% of the 255 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.05 vs. COO: 1.20 )
Ranked among companies with meaningful Price/Median PS Value only.
COO' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.26  Med: 1.01 Max: 1.84
Current: 1.2
0.26
1.84
Price/Peter Lynch Fair Value 2.59
COO's Price/Peter Lynch Fair Value is ranked lower than
56% of the 71 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. COO: 2.59 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
COO' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.68  Med: 1.25 Max: 3.9
Current: 2.59
0.68
3.9
Price/Graham Number 11.72
COO's Price/Graham Number is ranked lower than
94% of the 172 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.42 vs. COO: 11.72 )
Ranked among companies with meaningful Price/Graham Number only.
COO' s Price/Graham Number Range Over the Past 10 Years
Min: 1.27  Med: 2.60 Max: 18.18
Current: 11.72
1.27
18.18
Earnings Yield (Greenblatt) (%) 3.12
COO's Earnings Yield (Greenblatt) (%) is ranked higher than
59% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. COO: 3.12 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
COO' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.4  Med: 4.80 Max: 8.9
Current: 3.12
1.4
8.9
Forward Rate of Return (Yacktman) (%) 15.41
COO's Forward Rate of Return (Yacktman) (%) is ranked higher than
69% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.84 vs. COO: 15.41 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
COO' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -1.4  Med: 16.70 Max: 22.9
Current: 15.41
-1.4
22.9

More Statistics

Revenue(Mil) $1797
EPS $ 4.14
Beta0.44
Short Percentage of Float5.57%
52-Week Range $119.28 - 190.00
Shares Outstanding(Mil)48.27

Analyst Estimate

Oct16 Oct17
Revenue(Mil)
EPS($) 7.84 9.00
EPS without NRI($) 7.84 9.00

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, ISRG » details
Traded in other countries:CP6.Germany, COO.Mexico,
The Cooper Companies Inc is a Delaware corporation, which was organized on March 4, 1980. It is a medical device company. Through its subsidiaries, it manufactures products for contact lens wearers and supplies women's health clinicians with products and treatment options to improve the delivery of healthcare to women. It develops, manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring materials and optics. It products are designed to solve vision challenges such as astigmatism, presbyopia and ocular dryness; with a broad collection of spherical, toric and multifocal contact lenses. The Company's customers are healthcare professionals and institutions providing care to and for women. Its products support the point of healthcare delivery in the hospital, clinician's office and fertility clinics. The Company's manufacturing and distribution facilities are located in Trumbull, Connecticut, Malov, Denmark, Pasadena, California, Stafford, Texas, and Berlin, Germany. The Company's raw materials consist of various chemicals and packaging materials and are generally available from more than one source. It markets its products in the United States through field sales representatives, who call on optometrists, ophthalmologists, opticians, optical chains and distributors. The Company's products are medical devices subject to extensive regulation by the United States Food and Drug Administration (FDA) in the United States and other regulatory bodies abroad.
» More Articles for COO

Headlines

Articles On GuruFocus.com
Baron Funds Comments on The Cooper Companies Jan 26 2016 
Steve Mandel Buys Visa, DaVita Healthcare In Q4 Feb 19 2015 
DENTSPLY´s Growth Opportunities Dec 16 2014 
Weekly CEO Sells Highlight: Cooper Companies, Broadcom Corp, Realpage Inc, and Freescale Semiconduct Jul 14 2014 
Baron Funds Comments on The Cooper Companies May 02 2014 
CR Bard Focuses on Small to Medium-Sized Deals Apr 04 2014 
Manning & Napier New Buys of Q1 Apr 19 2013 
The Cooper Companies: Not Eyeing It Yet Nov 27 2012 
The Cooper Companies Inc. (COO) CEO - CSI Nicholas J Pichotta sells 6,602 Shares Jan 11 2011 
The Cooper Companies Inc. (COO) CEO - CSI Nicholas J Pichotta sells 2,650 Shares Dec 13 2010 

More From Other Websites
The Cooper Companies Announces Release Date for First Quarter 2016 Feb 08 2016
COOPER COMPANIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Feb 04 2016
The Cooper Cos., Inc. – Value Analysis (NYSE:COO) : February 4, 2016 Feb 04 2016
The Cooper Cos., Inc. breached its 50 day moving average in a Bullish Manner : February 4, 2016 Feb 04 2016
The Cooper Companies Declares Cash Dividend Jan 07 2016
The Cooper Companies Declares Cash Dividend Jan 07 2016
COOPER COMPANIES INC Financials Dec 24 2015
CooperVision & Its Employees Donate $125,000 to Optometry Giving Sight’s 2015 World Sight Day... Dec 23 2015
The Cooper Companies Sets Annual Meeting and Stockholder Record Dates Dec 22 2015
The Cooper Companies Sets Annual Meeting and Stockholder Record Dates Dec 22 2015
COOPER COMPANIES INC Files SEC form 10-K, Annual Report Dec 18 2015
The Cooper Companies' Women's Health Care Unit Acquires Research Instruments Dec 17 2015
The Cooper Companies’ Women’s Health Care Unit Acquires Research Instruments Dec 17 2015
The Cooper Companies to Present at J.P. Morgan Healthcare Conference Dec 16 2015
The Cooper Companies to Present at J.P. Morgan Healthcare Conference Dec 16 2015
The Cooper Cos., Inc. Earnings Analysis: Q4, 2015 By the Numbers Dec 09 2015
The Cooper Companies: Strong Sell on Weak Q4, Outlook Dec 07 2015
New Strong Sell Stocks for December 7th Dec 07 2015
What Is Going On With These Falling Stocks? Dec 04 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK